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A new concept, that ‘‘metabolic disorders, such as type 2 diabetes, are membrane microdomain dis-
orders caused by aberrant expression of gangliosides”, has arisen. By examining this working
hypothesis, we demonstrate the molecular pathogenesis of type 2 diabetes and insulin resistance
focusing on the interaction between insulin receptor and gangliosides in microdomains and pro-
pose the new therapeutic strategy ‘‘membrane microdomain ortho-signaling therapy”.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Gangliosides expressing cell-type speciﬁc manner are expected
to interact with various molecules on plasma membranes based on
different potentials of non-covalent bonding such as electrostatic
and hydrophobic interactions and thereby ganglioside family could
participate various aspects of cellular activities by forming dy-
namic functional complexes (membrane microdomains or lipid
rafts) in living cell membranes. Expression levels of cellular gan-
gliosides are known to be inﬂuenced by various extracellular stim-
uli including inﬂammatory cytokines. Namely, the presence of
gangliosides in membrane microdomains is reﬂecting the charac-
teristics of individual cells under pathophysiological environment.
Critical dependence of the insulin metabolic signal transduction
on caveolae/microdomains in adipocytes has been demonstrated.
These microdomains can be biochemically isolated at cold with
non-ionic detergents from cell membranes on the basis of their
lower density by sucrose gradient centrifugation, and were desig-
nated as detergent resistant membrane microdomains (DRM).
DRM are considered the experimental evidence of the existencechemical Societies. Published by E
e microdomains; Cav1, cave-
strate; SAT-I, GM3 synthase;
g; GEM, glycosphingolipid-of lipid rafts including caveolae and glycolipid-enriched membrane
microdomains (GEM). We observed the striking increase of cellular
ganglioside GM3 in the state of insulin resistance of mouse 3T3-L1
adipocytes induced by TNFa and in the adipose tissues of obese/
diabetic rodent models such as Zucker fa/fa rats and ob/ob mice
[1]. We examined the effect of TNFa on the composition and func-
tion of DRM in adipocytes and demonstrated that increased GM3
levels result in the elimination of insulin receptor (IR) from the
DRM while caveolin and ﬂotillin remain in the DRM, leading to
the inhibition of insulin’s metabolic signaling [2]. These ﬁndings
are further supported by the report that mice lacking GM3 syn-
thase exhibit enhanced insulin signaling [3]. To gain insight into
molecular mechanisms behind interactions of IR, caveolin-1
(Cav1) and GM3 in adipocytes, we performed immunoprecipita-
tions, cross-linking studies of IR and GM3, and live cell studies
using ﬂuorescence recovery after photobleaching (FRAP) tech-
nique. We found that (i) IR form complexes with Cav1 and GM3
independently; (ii) in GM3-enriched membranes the mobility of
IR is increased by dissociation of the IR-Cav1 interaction; (iii) the
lysine residue localized just above the transmembrane domain of
the IRb-subunit is essential for the interaction of IR with GM3.
Since insulin metabolic signal transduction in adipocytes is known
to be critically dependent on caveolae, we propose a new patholog-
ical feature of insulin resistance in adipocytes caused by dissocia-
tion of the IR-Cav1 complex by the interactions of IR with GM3
in microdomains [4].lsevier B.V. All rights reserved.
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Insulin elicits a wide variety of biological activities, which can
be globally categorized into metabolic and mitogenic actions.
The binding of insulin to insulin receptor (IR) activates IR inter-
nal-tyrosine kinase activity. The activated tyrosine-phosphory-
lated IR was able to recruit and phosphorylate adaptor proteins
such as insulin receptor substrate (IRS). The phosphorylated IRS
activates PI3-kinase, resulting in the translocation of glucose
transporter 4 (GLUT-4) to plasma membrane to facilitate glucose
uptake. This IR–IRS–PI3-kinase signaling cascade is the represen-
tative metabolic pathway of insulin. On the other hand, the
mitogenic pathway in insulin signaling initiates phosphorylation
of Shc by the activated IR and then activates Ras-MAPK
signaling.
When mouse adipocytes were cultured in low concentrations of
TNFa which do not cause generalized suppression of adipocyte
gene expression including IRS-1 and GLUT-4, interference of insu-
lin action by TNFa occurred [5]. This requires prolonged treatment
(at least 72 h), unlike many acute effects of this cytokine. The slow-
ness of the effect suggests that TNFa induces the synthesis of an
inhibitor that is the actual effector. We demonstrated that the state
of insulin resistance in adipocytes treated with 0.1 nM TNFa was
accompanied by a progressive increase in cell surface GM3. This
was reﬂected by increases in cellular GM3 content, GM3 synthase
activity and GM3 synthase mRNA content, indicating that TNFa
upregulates GM3 synthesis at the transcriptional level in cultured
adipocytes [1]. To elucidate whether the increased GM3 in 3T3-L1
adipocytes treated with TNFa is involved in insulin resistance, we
used an inhibitor of glucosylceramide synthase, D-threo-1-phenyl-
2-decanoylamino-3-morpholino-1-propanol (D-PDMP) [6] to de-
plete cellular glycosphingolipids derived from glucosylceramide.
D-PDMP proved able to counteract TNF-induced increase of GM3
content in adipocytes and completely normalize the TNF-induced
defect in tyrosine phosphorylation of IRS-1 in response to insulin
stimulation (Fig. 1A). These ﬁndings are supported by the recent
observation that knockout mouse lacking GM3 synthase exhibits
enhancement of insulin signaling [3].
Hotamisligil et al. reported that treatment of adipocytes with
TNFa induces an increase in the serine phosphorylation of IRS-1Fig. 1. TNFa increases the expression of GM3 and prevention of GM3 synthesis reverses T
cultured in maintenance medium without (lanes 1, 2 and 4) or with (lanes 3 and 5) 0.1
(lanes 4 and 5). Before insulin stimulation (100 nM for 3 min), cells were starved in seru
TNFa and D-PDMP as above for 8 h. Proteins in cell lysates were immunoprecipitated
Immobilon-P. Western blot was then proved with anti-phosphotyrosine monoclonal ant
were incubated in the absence or presence of TNFa and D-PDMP as in (A) and the gang[7]. This phosphorylation is an important event since immunopre-
cipitated IRS-1, which has been serine phosphorylated in response
to TNFa, is a direct inhibitor of insulin receptor tyrosine kinase
activity. We have shown that TNFa induced serine phosphoryla-
tion of IRS-1 in adipocytes was completely suppressed by inhibi-
tion of GM3 biosynthesis with D-PDMP treatment, suggesting
that the elevated GM3 synthesis induced by TNFa caused the
upregulation of serine phosphorylation of IRS-1 [1] (Fig. 1B). Since
TNF-induced serine phosphorylation of IRS-1 may occur through
the activation of a variety of kinases including protein kinase C,
c-Jun NH2-terminal kinase, p44/42 kinase, and PI3-kinase, it is
important to identify the actual kinase(s) activated by endogenous
GM3.
It was shown that adipose tissues of the obese-diabetic db/db,
ob/ob, KK-Ay mice and the Zucker fa/fa rat produced signiﬁcant lev-
els of TNFa [7]. Much less expression was seen in adipose tissues
obtained from the lean control animals. Interestingly, these ob-
ese-diabetic animals did not show evidence of altered expression
of other cytokines, such as IL-1 or IFNc [7,8]. Thus, we were inter-
ested in measuring the expression of GM3 synthase mRNA in the
epididymal fat of Zucker fa/fa rats and ob/ob mice. Northern blot
analysis of GM3 synthase mRNA contents in the adipose tissues
from these two typical models of insulin resistance exhibited sig-
niﬁcantly high levels compared to their lean counterparts (Fig. 2)
[1].
3. Caveolae microdomains and insulin signaling
Caveolae are a subset of membrane microdomains particularly
abundant in adipocytes [9,10]. Critical dependence of the insulin
metabolic signal transduction on caveolae/microdomains in adipo-
cytes has been demonstrated [11,12]. Disruption of microdomains
by cholesterol extraction with methyl-b-cyclodextrin resulted in
progressive inhibition of tyrosine phosphorylation of IRS-1 and
activation of glucose transport in response to insulin although
autophosphorylation of IR and activation of MAP kinase were not
impaired [9]. Similarities between these cell culture results and
the ﬁndings in many cases of clinical insulin resistance [13] sug-
gest a potential role for microdomains in the pathogenesis of this
disorder.NFa induced suppression insulin signaling in adipocytes (A) 3T3-L1 adipocytes were
nM TNFa for 96 h and in order to deplete GM3, 20 lM D-PDMP was also included
m-free media containing 0.5% bovine serum albumin in the absence or presence of
with antiserum to IR and IRS-1, fractionated by SDS–PAGE, and transferred to
ibody, stripped and reproved with antiserum to IR and IRS-1 (B) 3T3-L1 adipocytes
lioside fraction was visualized by resorcinol staining on HPTLC [1].
Fig. 2. Increased GM3 synthase mRNA in adipose tissue of typical rodent models of insulin resistance. Northern blot analysis of GM3 synthase mRNA was performed using
total mRNA from adipose tissues of ob/ob mice and Zucker fa/fa rats, and their lean counterparts [1].
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motif (fXXXXfXXf [f: an aromatic amino acid, X: any amino acid]
in the b subunit of IRs that could bind to the scaffold domain of
caveolin [14]. Moreover, mutation of this motif resulted in the inhi-
bition of insulin signaling [15]. Indeed, mutations of the IRb-sub-
unit have been found in type 2 diabetes patients [16]. Lisanti’s
laboratory reported that caveolin-1-null mice developed insulin
resistance when placed on a high fat diet [17] Interestingly, insulin
signaling, as measured by IR phosphorylation and its downstream
targets, was selectively decreased in the adipocytes of these ani-
mals while signaling in both muscle and liver cells was normal.
This signaling defect was attributed to a 90% decrease in IR protein
content in the adipocytes, with no changes in mRNA levels, indicat-
ing that caveolin-1 serves to stabilize the IR protein [12,17]. These
studies clearly indicate the critical importance of the interaction
between caveolin and IR in executing successful insulin signaling
in adipocytes.
Although the direct interaction between caveolin-1 and IR has
been shown as described above, studies of the presence of IRs in
DRM have provided conﬂicting data [18–22]. Saltiel and colleagues
found that insulin stimulation of 3T3-L1 adipocytes was associated
with tyrosine phosphorylation of caveolin-1 [23]. However, since
only trace levels of IR were recovered in the DRM in assays with
a buffer of 1% Triton X-100, they speculated on the presence of
intermediate molecule(s) bridging IR and caveolin [21]. Gustavsson
et al. also observed the dissociation of IRs from caveolin-containing
DRM after treatments of 0.3% and 0.1% Triton X-100 [18]. It has
been reported that a comparison of protein and lipid contents of
DRM prepared with a variety of detergents indicated considerable
differences in their ability to selectively solubilize membrane pro-
teins and to enrich sphingolipids and cholesterol over glycerophos-
pholipids and that Triton X-100 was the most reliable detergent
[24]. Therefore, we performed a ﬂotation assay with a wide range
of Triton X-100 concentrations to identify the protein of interest
which might weakly associate with DRM. In an assay systemTable 1
Localization of insulin receptor in caveolae microdomains is essential for the metabolic si
Function Evidence
Direct biding of IR and caveolin-1 IR has caveolin binding domain
Coimmunoprecipitation of IR and caveoli
Colocalization of IR and caveolin-1 IR and caveolin in light-density fractions
Fluorescence microscope
Electron microscope
Signaling Stimulation of caveolin-1 tyrosine phosp
Caveolin deﬁcient mice show insulin resi
Cholesterol depletion disrupts caveolae a
Increased GM3 eliminates IR from DRM acontaining less than 0.08% Triton X-100, we were able to show that
in normal adipocytes IRs can localize to DRM. Thus, by employing
low detergent concentrations we were able to demonstrate, for the
ﬁrst time, the presence of IR in DRM [2]. As summarized in Table 1,
there are many evidence demonstrating that the localization of IRs
in caveolae microdomains are essential for successful metabolic
signaling of insulin.
4. Insulin resistance as a membrane microdomain disorder
In a state of insulin resistance induced in adipocytes by TNFa
we presented evidence that the transformation to a resistant state
may depend on increased ganglioside GM3 biosynthesis following
upregulated GM3 synthase gene expression. Additionally, GM3
may function as an inhibitor of insulin signaling during chronic
exposure to TNFa [1]. Since GSL, including GM3, are important
components of DRM, we have pursued the possibility that in-
creased GM3 levels in DRM confer insulin resistance upon TNFa-
treated adipocytes. We examined the effect of TNFa on the compo-
sition and function of DRM in adipocytes and demonstrated that
increased GM3 levels result in the elimination of IRs from the
DRM while raft marker proteins such as caveolin and ﬂotillin re-
main in the DRM [2]. Although the localization of IRs to DRM
may be maintained by the association with caveolin-1 as men-
tioned above, the excess accumulation of GM3 in the DRM may
weaken IR–caveolin interaction. Therefore, to examine interactions
among IR, caveolin-1, and GM3 in 3T3-L1 adipocytes, we initially
performed coimmunoprecipitation assays. caveolin-1 has a scaf-
folding domain to which IR and other functional transmembrane
proteins bind through a caveolin binding domain in their cytoplas-
mic region [14,15]. As expected from another study [15], IR was co-
precipitated with Cav1 (Fig. 3A). GM3 was co-precipitated with IR
but not with Cav1 (Fig. 3B, upper panel). In addition, IR but not
Cav1 was co-precipitated with GM3 (Fig. 3B, lower panel). Thus,
IR can bind both Cav1 and GM3, but there is no interactiongnaling of insulin.
Reference
[14]
n [15]
by sucrose density ﬂoatation assay [2]
[18]
[40,41]
horylation by insulin [23,20]
stance due to accelerated degradation of IR in adipose tissue [17,20]
nd metabolic signaling of insulin [9]
nd inhibits IR-IRS-1 signaling [2,4]
Fig. 3. The insulin receptor forms distinct complexes with Cav1 and GM3 in adipocytes. (A) Coimmunoprecipitation assay of Cav1 and IR. Post nuclear supernatants (PNS) of
whole cell lysates were immunoprecipitated with an anti-Cav1 antibody or anti-mouse IgG (), and the precipitates were subjected to SDS–PAGE followed by
immunoblotting with an anti-IRb antibody. (B) GM3 associates with IR but not with Cav1. Upper panel: PNS were immunoprecipitated with an anti-Cav1 antibody, an anti-
IRb antibody, or an anti-mouse or anti-rat IgG (). The precipitates were subjected to TLC followed by immunostaining with the anti-GM3 antibody M2590 as described in
Section 2. Lower panel: Immunoprecipitation was performed with the anti-GM3 antibody DH2, in the presence or absence of 50 lg GM3, or with anti-mouse IgG (). The
precipitates were then subjected to SDS–PAGE followed by immunoblotting with an anti-IRb or anti-Cav1 antibody. (C) Cross-linking assay of GM3 and IR. Adipocytes were
treated with photoactivatable 3H-labeled GM3, washed, and then irradiated. Cells were then lysed and subjected to immunoprecipitation with an anti-IRb antibody. PNS, anti-
IRb immunoprecipitates (IP), and the supernatant from the immunoprecipitation (Sup) were subjected to SDS–PAGE, followed by immunoblotting with an anti-IRb antibody
and autoradiography [4].
J. Inokuchi / FEBS Letters 584 (2010) 1864–1871 1867between GM3 and Cav1, suggesting that IR can form distinct com-
plexes with each. The association between IR and GM3 was abol-
ished by the presence of GM3, conﬁrming the speciﬁc binding
ability of the anti-GM3 antibody to GM3 in the immunoprecipita-
tion medium (Fig. 3B, lower panel).
We next examined GM3–protein interactions occurring within
the plasma membrane of living cells by performing a cross-linking
assay using a photoactivatable radioactive derivative of GM3
(Fig. 3C). Adipocytes were preincubated with [3H]GM3(N3), then
irradiated to induce cross-linking of GM3. Target proteins were
then separated by SDS/PAGE and visualized by autoradiography.
A broad range of radioactivity reﬂecting GM3–protein complexes
could be detected from 80 kDa to 200 kDa, suggesting a close asso-
ciation between GM3 and a variety of cell surface proteins, includ-
ing IR. Moreover, a speciﬁc radioactive band corresponding to the
90-kDa IRb-subunit was immunoprecipitated with anti-IRb anti-
bodies, conﬁrming the direct association of GM3 and IR. Therefore,
we found that IR form complexes with caveolin-1 and GM3 inde-
pendently in 3T3-L1 adipocytes [4].
Lipids are asymmetrically distributed in the outer and inner
leaﬂets of plasma membranes. In typical mammalian cells, most
acidic phospholipids are located in the inner leaﬂet, and only acidic
glycosphingolipids such as sulfatides and gangliosides are in the
outer. The binding of proteins to lipid membranes is often medi-
ated by electrostatic interactions between the proteins’ basic do-
mains and acidic lipids. Gangliosides, which bear sialic acidresidues, exist ubiquitously in the outer leaﬂet of the vertebrate
plasma membrane. GM3 is the most abundant ganglioside, and
the primary ganglioside found in adipocytes [25]. Glyco-
sphingolipids, including gangliosides, share a common minimum
energy conformational structure in which the oligosaccharide
chain is oriented at a deﬁned angle to the axis of the ceramide
[26]. In addition, GM3 spontaneously forms clusters with its own
saturated fatty acyl chains, regardless of any repulsion between
the negatively charged units in the sugar chains [27]. Thus, GM3
clusters with other cell surface gangliosides such as GEM generate
a negatively charged environment just above the plasma mem-
brane. Conversely, IR has a sequence in its transmembrane domain,
homologous among mammals, that allows presentation of the ba-
sic amino acid lysine (IR944) just above transmembrane domain.
Therefore, during lateral diffusion an electrostatic interaction be-
tween the lysine residue at IR944 and the GM3 cluster could occur
due to their proximity on the plasma membrane (Fig. 4A).
We previously developed GM3-reconstituted cells by stably
transfecting the GM3 synthase (SAT-I) gene into GM3-deﬁcient
cells [28] (Fig. 4B, left panel). Using the ﬂuorescence recovery after
photobleaching (FRAP) technique, we examined the mobility of IR
in the plasma membranes of GM3-reconstituted (GM3 (+)) cells
and mock (GM3 ()) cells expressing equal levels of Cav1
(Fig. 4B, right panel inset). The mobility of IR-GFP expressed in
the GM3 (+) cells was statistically (10%) higher than that in the
GM3 () cells (Fig. 4B, right panel), providing further evidence that
Fig. 4. The lysine residue IR944 is essential for the interaction of IR with GM3. (A) Schematic representation of the proposed interaction of a lysine residue at IR944, which is
located just above the transmembrane domain, and GM3 at the cell surface. (B) Enhanced mobility of IR in GM3-enriched membrane. Left panel: Glycosphingolipid (GSL)
analysis of GM3-reconstituted cells (GM3 (+)) and mock cells (GM3 ()). GSLs extracted from these cells, corresponding to 1 mg of cellular protein, were separated on HPTLC
plates and stained with resorcinol–HCl reagent, to visualize gangliosides, or with cupric acetate–phosphoric acid reagent for neutral GSLs. Right panel: FRAP analyses.
Fluorescence recovery of IR-GFP in GM3 () and GM3 (+) cells expressing equal levels of Cav1(inset). (C) Speciﬁcity of the interaction between lysine at IR944 and GM3 by
FRAP analyses. Upper panel: Schematic structure of IR-GFP mutants in which the lysine at IR944 is replaced with basic and neutral amino acids. Lower panel: Fluorescence
recovery of IR-GFP mutants in GM3(+) cells [4].
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complex in living cells.
The binding of between IR and Cav1 has been studied in detail
[15]. To similarly understand interactions between IR and GM3
have not been analyzed. We constructed several mutants of IR in
which the lysine at IR944 was replaced with the basic amino acid,
arginine, or with the neutral amino acid valine, serine, or gluta-
mine. The ﬂuorescence recovery of IR(K944G), IR(K944S), and
IR(K944V) 100 s after bleaching was decreased by 10% compared
to those of IR(WT) and IR(K944R) in GM3 (+) cells. However, in
GM3 () cells, no such difference in the mobility between IR (wt)
and IR (K944S) was observed. This demonstrates that the lysine
in the wildtype is essential for its binding to GM3 due to its basic
charge [4].
IR may be constitutively resident in caveolae via its binding to
the scaffolding domain of caveolin-1 through the caveolin binding
domain in its cytoplasmic region [14]. In fact, there are many sup-
porting data showing that binding of IR and caveolin-1 is necessary
for successful insulin metabolic signaling (Table 1). Iwabuchi et al.
demonstrated that caveolae and GEM could be separated by an
anti-caveolin-1 antibody [29]. In adipocytes the localization of IR
in the caveolae is interrupted by elevated levels of the endogenous
ganglioside GM3 during a state of insulin resistance induced by
inﬂammatory response (e.g. TNFa) [1]. Our latest study has proven
a mechanism, at least in part, in which the dissociation of the IR–
caveolin-1 complex is caused by the interaction of a lysine residue,
located just above the transmembrane domain in IRb-subunit, and
the increased GM3 clustered at the cell surface by live cell studies
using FRAP techniques [4] (Fig. 4C). Here, we proposed mechanism
behind the shift of IR from the caveolae to the GEM in adipocytes
during a state of insulin resistance. Shown is a schematic represen-
tation of raft/microdomains comprising caveolae and non-caveolae
rafts such as GEM (Fig. 5).5. Serum GM3 levels as a new biomarker of metabolic disorder
GM3 is the major ganglioside present in serum and is known to
be associated with serum lipoproteins [30]. However, there have
been no studies examining a relationship between serum GM3 lev-
els and diabetes or abdominal obesity. So, we investigated the rela-
tionship between serum GM3 levels and adiposity indices, as well
as between serum GM3 levels and metabolic risk variables [31].
Serum GM3 levels were higher in hyperglycemic patients (1.4-
fold), hyperlipidemic patients (1.4-fold) and hyperglycemic pa-
tients with hyperlipidemia (1.6-fold), than in normal subjects. In
addition, serum GM3 levels were signiﬁcantly increased in type 2
diabetic patients with severe obesity (visceral fat area >200 cm2,
BMI >30). The GM3 level was positively correlated with LDL-c
(0.403, P = 0.012) in type 2 diabetes mellitus, but not affected by
blood pressure. In addition, the high levels of small dense LDL
(>10 mg/gl) were associated with the elevation of GM3. Serum
GM3 levels was affected by glucose and lipid metabolism abnor-
malities and by visceral obesity. Interestingly, small dense LDL is
reportedly associated with the development of atherosclerosis
[32–34], and GM3 has been detected in atherosclerotic lesions
[35,36]. Thus, our ﬁndings provide evidence that GM3 may be a
useful marker for the management of metabolic syndrome includ-
ing insulin resistance, as well as for the early diagnosis of
atherosclerosis.6. A possible therapeutic intervention of metabolic disorder by
inhibiting ganglioside synthesis
Critical involvement of ganglioside GM3 in insulin resistance
and metabolic syndrome including type 2 diabetes has now be-
came evident based on the following key observations; (i) TNFa
Fig. 5. Proposed mechanism behind the shift of insulin receptors from the caveolae to the glycosphingolipid-enriched microdomains (GEM) in adipocytes during a state of
insulin resistance. A schematic representation of raft/microdomains comprising caveolae and non-caveolae rafts such as GEM. Caveolae and GEM reportedly can be separated
by an anti-Cav1 antibody. IR may be constitutively resident in caveolae via its binding to the scaffolding domain of Cav1 through the caveolin-binding domain in its
cytoplasmic region. Binding of IR and Cav1 is necessary for successful insulin metabolic signaling (Table 1). In adipocytes the localization of IR in the caveolae is interrupted by
elevated levels of the endogenous ganglioside GM3 during a state of insulin resistance induced by TNFa [2]. The present study has proven a mechanism, at least in part, in
which the dissociation of the IR/Cav1 complex is caused by the interaction of a lysine residue at IR944, located just above the transmembrane domain, and the increased GM3
clustered at the cell surface [4].
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duced insulin resistance is prevented by treatment with a glucosyl-
ceramide synthase inhibitor, D-PDMP, and decreases GM3 contents
[1]. Recently, an improved PDMP analog [37,38] and another type
of glucosylceramide synthase inhibitor [39], were proven to have
therapeutic value by oral administration in diabetic rodent mod-
els.; (ii) GM3 contents increase in the adipose tissue of Zucker fa/
fa rats and ob/ob mice, which are typical rodent models of obesityFig. 6. Involvement of ganglioside GM3 in insulin resistance and metabolic disorder. He
under a chronic and low grade inﬂammation in bloated abdominal fat tissues. The bloated
release FFAs including palimitic acid. Palmitic acid is converted to palmitoyl CoA, whic
nucleotides including UDP-glucose and UDP-galactose increase due to the insulin resistan
which accompanied with the activation of GM3 synthase gene transcription by inﬂamma
membranes especially in lipid raft resulted in the dissociation of IR–caveiolin-1 comple
monocyte chemoattractant protein-1.[1] and diet induced obesity (unpublished observation); (iii) insu-
lin sensitivity is enhanced in GM3 synthase knockout mice [3]; (iv)
the accumulation of GM3 in insulin resistance results in dissocia-
tion of the insulin receptor from caveolae [2]; (v) dissociation of
the insulin receptor from caveolae is caused by electrostatic inter-
action between GM3 and the lysine residue (Lys-944) located just
above the transmembrane of the insulin receptor [4]; (vi) treat-
ment of glucosylceramide synthase inhibitors signiﬁcantly im-re we propose a pathway of insulin resistance caused by the elevated levels of GM3
fat tissue in the state of insulin resistance is no more able to store triglycerides and
h is a substrate for sphingosine biosynthesis. At the same time, the levels of sugar
ce. These events accelerate the biosynthesis of GM3 in the state of insulin resistance
tory cytokines including TNFa. Consequently, the elevated levels of GM3 in plasma
x, leading to the attenuation of insulin signaling as summarized in Fig. 5. MCP-1:
1870 J. Inokuchi / FEBS Letters 584 (2010) 1864–1871proved insulin sensitivity and glucose homeostasis in rodent mod-
els of obesity [37,40]. Taken together, a new therapeutic interven-
tion by inhibiting GM3 biosynthesis can be proposed for the
treatment of metabolic syndrome including type 2 diabetes.
7. Concluding remarks
A growing body of evidence implicates glycosphingolipids
including gangliosides in the pathogenesis of insulin resistance.
We demonstrated that in 3T3-L1 adipocytes in a state of TNF-in-
duced insulin resistance, the inhibition of insulin metabolic signal-
ing was associated with an accumulation of the ganglioside GM3
[1], and, moreover, the pharmacological inhibition of GM3 biosyn-
thesis by the glucosylceramide synthase inhibitors proved to be
effective to ameliorate the state of insulin resistance induced
in vitro and obese rodent models, suggesting a new target for ther-
apy against insulin resistance and type 2 diabetes [1,37–39]. In
addition, our data substantiate a rationale for designing novel ther-
apies against type 2 diabetes and related diseases based on inhibi-
tion of ganglioside biosynthesis [4]. The extensive reduction of all
gangliosides by inhibiting GM3 biosynthesis would carry to impor-
tant physical and chemical modiﬁcations of the all cellular plasma
membrane and in particular of lipid microdomains. However, we
expect that such extensive depletion of gangliosides will not be
necessarily for the treatment of metabolic disorders. When we
demonstrated the effectiveness of D-PDMP on the impaired insulin
signaling in TNFa-treated 3T3-L1 adipocytes, the normalization of
elevated levels of GM3 was enough to ameliorate the state of insu-
lin resistance [1]. Thus, a new therapeutic intervention by inhibit-
ing GM3 biosynthesis for the treatment of metabolic syndrome
including type 2 diabetes will be proved for clinical usefulness.
Here I have summarized the distinct pathway of metabolic disor-
der including the aberrant expression of GM3 (Fig. 6).
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